Status:
COMPLETED
Acute Tocolysis With Terbutaline for Suspected Fetal Distress
Lead Sponsor:
Hospital Kemaman
Conditions:
Nonreassuring Fetal Status
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The trial was to determine the effect of administrating subcutaneous terbutaline prior to emergency caesarean delivery for suspected fetal distress
Detailed Description
The trial was a double-blinded, placebo-controlled study using subcutaneous terbutaline for acute tocolysis prior to emergency caesarean delivery in suspected fetal distress. The intervention (subcuta...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- term singleton pregnancy
- cephalic presentation
- in labour with cervix dilatation \> 4cm and regular uterine contractions of 3 or more 10 min
- abnormal fetal heart rate status diagnosed using standard electronic FHR according to NICE guideline (2014)
- acceptance of participation by the signing of a written consent.
- Exclusion Criteria
- maternal cardiopathy
- hyperthyroidism
- abruptio placentae or other placental accidents
- hypertensive disease of pregnancy
- hyperstimulation with oxytocin
- multiple gestation
- abnormal fetus planned for conservative management
- evidence of intrauterine growth restriction
- patient on medication which will interact with terbutaline (tricyclic antidepressants, beta-blockers, diuretics and sympathomimetic medicine).
Exclusion
Key Trial Info
Start Date :
April 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05326269
Start Date
April 23 2017
End Date
September 15 2019
Last Update
April 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Kemaman
Kuala Terengganu, Terengganu, Malaysia, 24000